The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant therapy (NAT) and its role for pancreatic adenocarcinoma (PC) in the current era: Institutional experience.
 
Emily Walzer
No Relationships to Disclose
 
Mengying Deng
No Relationships to Disclose
 
Elizabeth A. Handorf
Research Funding - Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst)
 
Aryeh Blumenreich
No Relationships to Disclose
 
Lauren Pease
No Relationships to Disclose
 
Marianna Dorta
No Relationships to Disclose
 
Kristen Sorice
No Relationships to Disclose
 
Shannon M. Lynch
No Relationships to Disclose
 
Namrata Vijayvergia
Research Funding - Bayer; Bayer; Bayer; Bayer; Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst)
 
Efrat Dotan
Honoraria - Boston Biomedical; Boston Biomedical; Boston Biomedical; Boston Biomedical; Pfizer; Pfizer; Pfizer; Pfizer
Consulting or Advisory Role - ARMO BioSciences; ARMO BioSciences; ARMO BioSciences; ARMO BioSciences; Boston Biomedical; Boston Biomedical; Boston Biomedical; Boston Biomedical
Research Funding - Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb